78
Views
36
CrossRef citations to date
0
Altmetric
Original Article

Methadone Maintenance and Recovery from Opioid Dependence

&
Pages 63-74 | Published online: 07 Jul 2009

References

  • Cooper J. R. Methadone treatment and acquired immunodeficiency syndrome. J. Am. Med. Assoc 1989; 262: 1664–1668
  • Dole V. P., Nyswander M. E., Warner A. Successful treatment of 750 criminal addicts. J. Am. Med. Assoc 1968; 206: 2708–2711
  • Maddux J. F., McDonald L. K. Status of 100 San Antonio addicts one year after admission to methadone maintenance. Drug Forum 1973; 2: 239–252
  • Gearing F. R. Methadone maintenance treatment five years later. Where are they now?. Am. J. Public Health 1974; 64: 44–50, (Suppl.)
  • Cushman P., Jr. Ten years of methadone maintenance treatment: Some clinical observations. Am. J. Drug Alcohol Abuse 1977; 4: 543–553
  • Senay E. C. Methadone maintenance treatment. Int. J. Addict. 1985; 20: 803–821
  • Ball J. C., Lange W. P., Myers C. P. Reducing the risk of AIDS through methadone maintenance treatment. J. Health Soc. Behav. 1988; 29: 214–226
  • Kolb L. The struggle for cure and the conscious reasons for relapse. J. Nerv. Ment. Dis. 1927; 66: 22–43, (Reprinted in Kolb, L., Drug Addiction Thomas, Springfield, Illinois, 1962)
  • Himmelsbach C. K. Clinical studies of drug addiction. Physical dependence, withdrawal, and recovery. Arch. Intern. Med. 1942; 69: 766–772
  • Martin W. R. Pathophysiology of narcotic addiction: Possible roles of protracted abstinence in relapse. Drug Abuse: Proceedings of the International Conference, C. J. D. Zarafonetis. Lea and Febiger, Philadelphia 1972; 152–159
  • Martin W. R., Jasinski D. R., Haertzen C. A. Methadone–A reevaluation. Arch. Gen. Psychiatry 1973; 28: 286–295
  • Goldstein A. Opioid peptides (endorphins) in pituitary and brain. Science 1976; 193: 1081–1086
  • Dole V. P. Implications of methadone maintenance for theories of narcotic addiction. J Am. Med. Assoc. 1988; 260: 3025–3029
  • Progress in Opioid Research. Proceedings of the 19th International Research Conference, J. Cros, J.-C. Meunier, M. Hamon. Pergamon Press, New York 1989
  • Kolb L. Drug addiction as a public health problem. Sci. Mon. 1939; 48: 391–400
  • Wilder A., Pescor F. T. Classical conditioning of a morphine abstinence phenomenon, reinforcement of opioid-drinking behavior, and “relapse” in morphine-addicted rats. Psychophar-macologia 1967; 10: 255–284
  • Wikler A. Opioid Dependence. Plenum Press, New York 1980
  • O'Brien C. P., Testa T., O'Brien T. J. Conditioned narcotic withdrawal in humans. Science 1977; 195: 1000–1002
  • Meyer R. E., andMirin S. M. The Heroin Stimulus: Implications for a Theory of Addiction. Plenum Press, New York 1979
  • Learning Factors in Substance Abuse, B. A. Ray. National Institute on Drug Abuse Research Monograph 84. DHHS Publication (ADM)88-1576, Department of Health and Human Services, Rockville, Maryland 1988
  • Jaffe J. H. Further experience with methadone in the treatment of narcotics users. Methadone Maintenance, S. Einstein. Dekker, New York 1971; 29–43
  • Bale R. N., Van Stone W. W., Kuldau J. M. Therapeutic communities vs. methadone maintenance. Arch. Gen. Psychiatry 1980; 37: 179–193
  • Hargreaves W. A. Methadone dosage and duration for maintenance treatment. Research on the Treatment of Narcotic Addiction, J. R. Cooper, F. Altaian, B. S. Brown, D. Czechowitz. Department of Health and Human Services, Rockville, Maryland 1983; 19–79
  • Goldstein A., Judson B. A. Critique of Hargreaves paper. Research on the Treatment of Narcotic Addiction. 80–91, Reference 23 above
  • Dole V. P., Joseph H. Long-term outcome of patients treated with methadone maintenance. Ann. N. Y. Acad. Sci. 1978; 311: 181–189
  • Cushman P., Jr. Detoxification after methadone maintenance treatment. Ann. N. Y. Acad. Sci. 1981; 362: 217–230
  • Judson B. A., Ortiz S., Crouse L. A followup study of heroin addicts five years after first admission to a methadone treatment program. Drug Alcohol Depend. 1980; 6: 295–313
  • McGlothlin W. H., Anglin M. D. Long-term followup of clients of high- and low-dose methadone programs. Arch. Gen. Psychiatry 1981; 38: 1055–1063
  • Simpson D. D., Joe G. W., Bracy S. A. Six-year followup of opioid addicts after admission to treatment. Arch. Gen. Psychiatry 1982; 39: 1318–1323
  • Oppenheimer E., Stimson G. V., Thorley A. Seven-year followup of heroin addicts: Abstinence and continued use compared. Br. Med. J. 1979; 2: 627–630
  • Oppenheimer E., Stimson G. V. Seven year followup of heroin addicts: Life histories summarized. Drug Alcohol Depend. 1982; 9: 153–159
  • Duvall H. J., Locke B. Z., Brill L. Followup study of narcotic drug addicts five years after hospitalization. Public Health Rep. 1963; 78: 185–193
  • O'Donnell J. A. Narcotic Addicts in Kentucky (PHS Publication 1881). Department of Health, Education, and Welfare, Chevy Chase, Maryland 1969
  • Vaillant G. E. A 20-year followup of New York narcotic addicts. Arch. Gen. Psychiatry 1973; 29: 237–241
  • Whitman B. Y., Croughan J. L., Miller J. P. Nonpsychiatric predictors of narcotic dependence: A prospective study with a 5-year followup. Int. J. Addict. 1982; 17: 473–491
  • Rawson R. A., Tennant F. S., Jr. Five-year followup of opiate addicts with naltrexone and behavior therapy. Problems of Drug Dependence 1983, L. S. Harris. National Institute on Drug Abuse Researc Monograph 49. DHHS Publication No. (ADM) 84-1316, Department of Health and Human Services, Rockville, Maryland 1984; 289–295
  • Romond A. M., Forrest C. K., Andkleber H. D. Followup of participants in a drug dependence therapeutic community. Arch. Gen. Psychiatry 1975; 32: 369–374
  • Coombs R. H. Back on the streets: Therapeutic communities' impact upon drug users. Am. J. Drug Alcohol Abuse 1981; 8: 185–210
  • De Leon G. The Therapeutic Community: Study of Effectiveness [National Institute on Drug Abuse Treatment Research Monograph Series. DHHS Publication (ADM)84-1286]. Department of Health and Human Services, Rockville, Maryland 1984
  • Bale R. N., Zarcone V. P., VanStone W. W. Three therapeutic communities. Arch. Gen. Psychiatry 1984; 41: 185–191

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.